GGrantIndex
← Search

PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER

$321,374M01FY2002RRNIH

University Of Texas Sw Med Ctr/Dallas, Dallas TX

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →